25I-NBOMe is a derivative of the phenethylamine hallucinogen 2C-I (D470000), discovered in 2003. 25I-NBOMe acts as a highly potent agonist for the human 5-HT2A receptor. The drug is not active orally and must be taken buccally, sublingually or intranasally. This product can only be used for chemical research.
